Vaxcyte Stock Odds of Future Stock Price Finishing Under 60.62

PCVX Stock  USD 87.08  0.55  0.64%   
Vaxcyte's future price is the expected price of Vaxcyte instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Vaxcyte performance during a given time horizon utilizing its historical volatility. Check out Vaxcyte Backtesting, Vaxcyte Valuation, Vaxcyte Correlation, Vaxcyte Hype Analysis, Vaxcyte Volatility, Vaxcyte History as well as Vaxcyte Performance.
For more information on how to buy Vaxcyte Stock please use our How to Invest in Vaxcyte guide.
  
Please specify Vaxcyte's target price for which you would like Vaxcyte odds to be computed.

Vaxcyte Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Vaxcyte for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Vaxcyte can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Vaxcyte generated a negative expected return over the last 90 days
Net Loss for the year was (402.27 M) with loss before overhead, payroll, taxes, and interest of (23 M).
Vaxcyte currently holds about 354.5 M in cash with (296.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.98.
Vaxcyte has a poor financial position based on the latest SEC disclosures
Over 100.0% of the company shares are owned by institutional investors

Vaxcyte Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Vaxcyte Stock often depends not only on the future outlook of the current and potential Vaxcyte's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vaxcyte's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding97.2 M
Cash And Short Term Investments1.1 B

Vaxcyte Technical Analysis

Vaxcyte's future price can be derived by breaking down and analyzing its technical indicators over time. Vaxcyte Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Vaxcyte. In general, you should focus on analyzing Vaxcyte Stock price patterns and their correlations with different microeconomic environments and drivers.

Vaxcyte Predictive Forecast Models

Vaxcyte's time-series forecasting models is one of many Vaxcyte's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Vaxcyte's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Vaxcyte

Checking the ongoing alerts about Vaxcyte for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Vaxcyte help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Vaxcyte generated a negative expected return over the last 90 days
Net Loss for the year was (402.27 M) with loss before overhead, payroll, taxes, and interest of (23 M).
Vaxcyte currently holds about 354.5 M in cash with (296.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.98.
Vaxcyte has a poor financial position based on the latest SEC disclosures
Over 100.0% of the company shares are owned by institutional investors

Additional Tools for Vaxcyte Stock Analysis

When running Vaxcyte's price analysis, check to measure Vaxcyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxcyte is operating at the current time. Most of Vaxcyte's value examination focuses on studying past and present price action to predict the probability of Vaxcyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxcyte's price. Additionally, you may evaluate how the addition of Vaxcyte to your portfolios can decrease your overall portfolio volatility.